Histogram analysis of dynamic contrast-enhanced magnetic resonance imaging in the differential diagnosis of parotid tumors

Objective Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) histograms were used to investigate whether their parameters can distinguish between benign and malignant parotid gland tumors and further differentiate tumor subgroups. Materials and methods A total of 117 patients (32 malignant and 85 benign) who had undergone DCE-MRI for pretreatment evaluation were retrospectively included. Histogram parameters including mean, median, entropy, skewness, kurtosis and 10th, 90th percentiles were calculated from time to peak (TTP) (s), wash in rate (WIR) (l/s), wash out rate (WOR) (l/s), and maximum relative enhancement (MRE) (%) mono-exponential models. The Mann–Whitney U test was used to compare the differences between the benign and malignant groups. The diagnostic value of each significant parameter was determined on Receiver operating characteristic (ROC) analysis. Multivariate stepwise logistic regression analysis was used to identify the independent predictors of the different tumor groups. Results For both the benign and malignant groups and the comparisons among the subgroups, the parameters of TTP and MRE showed better performance among the various parameters. WOR can be used as an indicator to distinguish Warthin’s tumors from other tumors. Warthin’s tumors showed significantly lower values on 10th MRE and significantly higher values on skewness TTP and 10th WOR, and the combination of 10th MRE, skewness TTP and 10th WOR showed optimal diagnostic performance (AUC, 0.971) and provided 93.12% sensitivity and 96.70% specificity. After Warthin’s tumors were removed from among the benign tumors, malignant parotid tumors showed significantly lower values on the 10th TTP (AUC, 0.847; sensitivity 90.62%; specificity 69.09%; P  < 0.05) and higher values on skewness MRE (AUC, 0.777; sensitivity 71.87%; specificity 76.36%; P  < 0.05). Conclusion DCE-MRI histogram parameters, especially TTP and MRE parameters, show promise as effective indicators for identifying and classifying parotid tumors. Entropy TTP and kurtosis MRE were found to be independent differentiating variables for malignant parotid gland tumors. The 10th WOR can be used as an indicator to distinguish Warthin’s tumors from other tumors.

[1]  Faiza Admiraal-Behloul,et al.  Reproducibility of brain ADC histograms , 2004, European Radiology.

[2]  Jingliang Cheng,et al.  Apparent diffusion coefficient (ADC) histogram analysis: Differentiation of benign from malignant parotid gland tumors using readout-segmented diffusion-weighted imaging. , 2019, Dento maxillo facial radiology.

[3]  H. Matsuzaki,et al.  Assessment of pleomorphic adenomas using MRI and dynamic contrast enhanced MRI. , 2003, Oral oncology.

[4]  N. Just,et al.  Improving tumour heterogeneity MRI assessment with histograms , 2014, British Journal of Cancer.

[5]  T. Kurabayashi,et al.  Differentiating benign and malignant salivary gland tumours: diagnostic criteria and the accuracy of dynamic contrast-enhanced MRI with high temporal resolution. , 2015, The British journal of radiology.

[6]  Publisher's Note , 2018, Anaesthesia.

[7]  Xiaofeng Tao,et al.  The histogram analysis of apparent diffusion coefficient in differential diagnosis of parotid tumor. , 2020, Dento maxillo facial radiology.

[8]  C. West,et al.  Dynamic contrast-enhanced magnetic resonance imaging biomarkers in head and neck cancer: potential to guide treatment? A systematic review. , 2014, Oral oncology.

[9]  Jeong Hyun Lee,et al.  Detection of Local Tumor Recurrence After Definitive Treatment of Head and Neck Squamous Cell Carcinoma: Histogram Analysis of Dynamic Contrast-Enhanced T1-Weighted Perfusion MRI. , 2017, AJR. American journal of roentgenology.

[10]  A. Surov,et al.  Associations between histogram analysis parameters derived from dynamic-contrast enhanced MRI and PD L1-expression in head and neck squamous cell carcinomas. A preliminary study. , 2020, Magnetic resonance imaging.

[11]  E. Gökçe Multiparametric Magnetic Resonance Imaging for the Diagnosis and Differential Diagnosis of Parotid Gland Tumors , 2020, Journal of magnetic resonance imaging : JMRI.

[12]  R. Spiro Salivary neoplasms: overview of a 35-year experience with 2,807 patients. , 1986, Head & neck surgery.

[13]  Weiqing Gao,et al.  The value of combining conventional, diffusion-weighted and dynamic contrast-enhanced MR imaging for the diagnosis of parotid gland tumours. , 2017, Dento maxillo facial radiology.

[14]  H. Huisman,et al.  Correlation between dynamic contrast-enhanced MRI and quantitative histopathologic microvascular parameters in organ-confined prostate cancer , 2014, European Radiology.

[15]  H. Shindo,et al.  [Salivary gland masses: dynamic MR imaging and pathologic correlation]. , 1997, Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica.

[16]  Peng Cao,et al.  Benign and malignant orbital lymphoproliferative disorders: Differentiating using multiparametric MRI at 3.0T , 2017, Journal of magnetic resonance imaging : JMRI.

[17]  A. Parwani,et al.  Diagnostic accuracy and pitfalls in fine‐needle aspiration interpretation of Warthin tumor , 2003, Cancer.

[18]  T. Yoshiura,et al.  Value of diffusion tensor imaging in differentiating malignant from benign parotid gland tumors. , 2017, European journal of radiology.

[19]  P. Westesson,et al.  Tumors of the parotid gland: MR imaging characteristics of various histologic types. , 1994, AJR. American journal of roentgenology.

[20]  M. Fležar,et al.  Warthin's tumour: unusual vs. common morphological findings in fine needle aspiration biopsies , 2002, Cytopathology : official journal of the British Society for Clinical Cytology.

[21]  K. Mackenzie,et al.  Fine‐needle aspiration cytology of salivary gland: A review of 341 cases , 2000, Diagnostic cytopathology.

[22]  Hidetake Yabuuchi,et al.  Index terms: , 2002 .

[23]  H. Matsuzaki,et al.  Diagnostic value of dynamic contrast-enhanced MRI in the salivary gland tumors. , 2007, Oral oncology.

[24]  T. Murakami,et al.  Contrast‐enhanced MR imaging of intrahepatic cholangiocarcinoma: Pathologic correlation study , 1995, Journal of magnetic resonance imaging : JMRI.

[25]  Steven R. Breault,et al.  Reproducibility of dynamic contrast-enhanced MR imaging. Part II. Comparison of intra- and interobserver variability with manual region of interest placement versus semiautomatic lesion segmentation and histogram analysis. , 2013, Radiology.

[26]  Jong-Hee Chang,et al.  Primary central nervous system lymphoma and atypical glioblastoma: differentiation using the initial area under the curve derived from dynamic contrast-enhanced MR and the apparent diffusion coefficient , 2017, European Radiology.

[27]  W. Qian,et al.  Histogram analysis of apparent diffusion coefficient maps for differentiating malignant from benign parotid gland tumors , 2018, European Archives of Oto-Rhino-Laryngology.

[28]  Hu Liu,et al.  Histogram analysis of dynamic contrast-enhanced magnetic resonance imaging for differentiating malignant from benign orbital lymphproliferative disorders , 2019, Acta radiologica.

[29]  H. Matsuzaki,et al.  Assessment of dynamic MRI of Warthin's tumors arising as multiple lesions in the parotid glands. , 2002, Oral oncology.

[30]  Tao Zhang,et al.  Magnetic resonance image biomarkers improve differentiation of benign and malignant parotid tumors through diagnostic model analysis , 2021, Oral Radiology.

[31]  Philip Cole,et al.  Incidence Rates of Salivary Gland Tumors: Results from a Population-Based Study , 1999, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.